Market Size (2016)
2016
$22.27B
Vertical: HealthcareBase Year: 201811 Sections
Market Size (2016)
2016
$22.27B
Projected (2025)
2025
$89.36B
CAGR (2016–2025)
16.7%
16.7%Key Players
104+
Game-based neurorehabilitation systems have the potential to encourage patients in continuing rehabilitation exercises at home. The use of games in neurorehabilitation offers patients an opportunity to participate in an exercise program that is fun, engaging, and at the same time, beneficial to address their disabilities.
The factors leading to the growth of the global neurorehabilitation gaming systems market are increasing geriatric population, rising neurological diseases, and increasing product launches & approvals. However, stringent regulatory policies and requirements of skilled professionals are the posing hurdles to the market growth on the global level.
The Neurorehabilitation Gaming Systems Market market is projected to grow at a CAGR of 16.7% from 2016 to 2025.
Historical performance and future projections (2020–2030, USD Billion)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Size (USD Mn)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansGame-based neurorehabilitation is the area of research pertaining to the use of technology within the field of physiotherapy. Irrespective of the cause of impairment, the main aim of most neurological rehabilitation is to facilitate learning or relearning of motor skills. Traditional rehabilitation is time-consuming and requires costly and lengthy sessions with therapists. Game-based neurorehabilitation systems have the potential to encourage patients in continuing rehabilitation exercises at home. The use of the games in neurorehabilitation offers patients an opportunity to participate in an exercise program that is fun, engaging, and at the same time, beneficial to address their disabilities. Current research indicates that the use of virtual reality as an adjunct to traditional rehabilitation is an economically beneficial approach and ensure optimal rehabilitation of patients with neurological disorders.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansThis report applies a rigorous multi-stage research process combining primary interviews, secondary data sources, and bottom-up market modelling to ensure accuracy and completeness across all segments and geographies.
Base Year
2018
Historical Period
2016 – 2018
Forecast Period
2018 – 2025
Primary Interviews
150+
Historical data (2016–2018) and forecast period (2018–2025)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansThreat of New Entrants
The threat of new entrants is moderate to high in the global neurorehabilitation gaming systems market. Any neurorehabilitation gaming systems developing company trying to enter the market are required to accept or abide by the mandatory regulatory standards. The neurorehabilitation gaming systems market was also characterized by a reasonable degree of brand loyalty, which is now turning out that the end users are opting for new software demos instead of choosing the most popular software. Moreover, the increasing use of technology in the healthcare industry is influencing many of the start-ups to take a keen interest in the field of healthcare IT, which increases the possibility of new entrants in the market.
Bargaining Power of Suppliers
The suppliers in the global neurorehabilitation gaming systems industry are the developers of the neurorehabilitation gaming systems. There is a limited number of suppliers in the global neurorehabilitation gaming systems market, which leads to a moderate amount of bargaining power in the market. Additionally, the switching cost of these suppliers is low as suppliers tend to enter into long term associations with the software developers. However, some companies in developing countries offer the software at a relatively lower price due to low healthcare expenditure, which reduces the profit potential of the neurorehabilitation gaming systems industry.
Threat Of Substitutes
The threat of substitutes in the global neurorehabilitation gaming systems market is low. There are very a smaller number of substitutes present for the neurorehabilitation gaming systems that pose a moderate threat to the global neurorehabilitation gaming systems market. Buyers’ inclination towards substitutes is low due to their less availability. Additionally, the high degree of switching cost minimizes the threat of substitutes.
Bargaining Power of Buyers
The bargaining power of buyers is low in the global neurorehabilitation gaming systems market. The market consists of a limited number of buyers, including neurological patients. Furthermore, the market is characterized by a low degree of brand identity. Moreover, the buyers can exert moderate pressure on the neurorehabilitation gaming systems developers as they already provide high-quality software. Therefore, due to a moderate level of services provided by the neurorehabilitation gaming systems manufacturers, the bargaining power of suppliers tends to be low.
Intensity Of Rivalry
The degree of competition in the neurorehabilitation gaming systems market is low to moderate. The restrained degree of product differentiation among existing players increases the intensity of rivalry in the market. Neurorehabilitation gaming systems developing companies are trying to create less expensive systems to make procedures more affordable in developing regions. To overcome the competition, players are engaged in developing low-cost solutions. Moreover, the players are more focused on developing advanced systems to overcome their rivals.
Market estimates by geography (2025)
InsightAmericas leads with $39.25B by 2025, while Asia Pacific is projected to grow fastest at a 16.9% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2016 | 2018 | 2025 | CAGR | SHARE |
|---|---|---|---|---|---|
| Americas | $9.69B | $20.76B | $39.25B | 16.8% | 44% |
| Asia Pacific | $4.18B | $9.00B | $17.08B | 16.9% | 19% |
| Europe | $6.42B | $13.69B | $25.79B | 16.7% | 29% |
| Rest of the World | $1.97B | $4.01B | $7.24B | 15.5% | 8% |
| Total | $22.27B | $47.44B | $89.36B | 16.7% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$89.36B
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Hardware | $61.14B | 16.7% | 89% |
| Software | $28.22B | 16.7% | 89% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.

Analytical insights on Neurorehabilitation Gaming Systems Market covering market dynamics, competitive landscape, and strategic outlook.
The Neurorehabilitation Gaming Systems Market market is projected to reach $89.36B by 2025, growing at 16.7% CAGR. The Hardware segment holds the largest share.
The use of virtual reality (VR) as an adjunct to traditional rehabilitation in neurological patients is promising. Consoles and tablets are commercially available, affordable, and safe to use to supplement rehabilitation of neurological conditions. Games applied in the field of neurorehabilitation are helping to improve the process of motor learning and recovery from incidents of stroke, traumatic brain injury, and other neuromuscular impairment by increasing user motivation during training. However, these systems are still rarely adopted at patients’ homes. Discovering and eliminating the obstacles in promoting game-based rehabilitation at home is therefore essential.
Rising neurological disorders, the effectiveness of the gaming system in neurorehabilitation, surge in the geriatric population, and increasing product launches and approvals by key players are expected to drive the growth of the neurorehabilitation gaming systems market. However, stringent regulatory policies and requirements of skilled professionals are expected to hamper the growth of the market.
The market is expected to witness a profitable growth owing to the rise in neurological disorders such as Parkinson’s, Alzheimer’s, stroke, epilepsy, multiple sclerosis, and essential tremors. Stroke is the third leading cause of death in the US. More than 140,000 people die each year from stroke in the country. About 87% of all strokes are ischemic strokes, in which blood flow to the brain is blocked. As per the statistics of the World Health Organization (WHO), an estimated 5 million people are diagnosed with epilepsy each year globally. Additionally, every year, approximately 250,000 to 500,000 people suffer a spinal cord injury (SCI) around the world. Furthermore, the Multiple Sclerosis Society UK estimated that there are around 100,000 people with multiple sclerosis (MS) in the UK and each year, 5,000 people are newly diagnosed with the condition.
Neurodegenerative disorders may lead to persistent or permanent functional limitations, including paralysis, abnormal control of movements, loss of coordination, loss of range of motion, abnormal posture, spasticity, memory deficits, spatial neglect, aphasia, and dyspraxia, among others. This functional limitation severely impacts a person’s ability to perform activities of daily living. The rehabilitation of neurological disorder requires repetitive, intensive, and goal-oriented therapy. Virtual reality (VR) has the potential to satisfy these requirements. Game-based therapy can promote patients' engagement in rehabilitation therapy as an interesting and motivating tool.
Thus, the rise in neurological disorders has heightened the demand for neurorehabilitation gaming systems, which is positively influencing the growth of the market.
The rehabilitation gaming system offers a powerful opportunity to increase patient motivation and adherence to training in neurorehabilitation but is currently limited in its systemic applicability. For successful implementation of games in mainstream rehabilitation programs, there is a need for the development of an integrated rehabilitation software platform that supports existing systemic relationships and methodologies. At present, a major criticism of existing gaming scenarios for rehabilitation is that they have been designed primarily by engineers, scientists, and health professionals. They intend to build and test the overall functionality of specific research-based hardware. The games themselves often lack the qualities required to be motivational for patients for the long-term. It is extremely important to keep the level of challenge optimal to stimulate intrinsic motivation during training. The task should be presented playfully and should elicit a game-like experience, but it should be designed to reflect the daily activities of the user, while the parameters recorded should be determined based on the neurorehabilitation practice. Moreover, there is a need for increased awareness among people suffering from neurological disorders about the neurorehabilitation gaming system. This is likely to create an opportunity for the manufacturers to develop innovative gaming platforms which suits diverse needs of user.
The manufacturing of neurorehabilitation systems follows crucial steps and processes. These processes differ from the manufacturer, country regulations, the adoption rate of the country, and the pricing of devices in the region. Companies must comply with the Food and Drug Administration (FDA) regulations in the US and CE mark in the EU to launch their products in respective regions. In some economies such as Japan and China regulatory processes are given utmost importance. The healthcare regulatory authorities of these countries employ strict policies and processes for the approval of products. In November 2014, the Japanese pharmaceutical and medical device market underwent significant changes due to the replacement of the Japanese Pharmaceutical Affairs Law (JPAL) with the new Pharmaceutical and Medical Device Act (PMD Act). The PMD Act affects major areas of medical device regulations, including quality management system compliance, device registration, the regulation of medical software, and third-party certifications. To market medical devices in Japan, manufacturers must be compliant with the current PMD Act.
This changing regulatory scenario is restricting manufacturers to produce neurorehabilitation gaming systems in different regions, and this may act as a factor that would curb the growth of the market in the future.
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Profiles of 104 companies operating in the Neurorehabilitation Gaming Systems Market market, including revenue, employee count, and market positioning where available.
Showing 104 of 104 companies
Neofect
Company Headquarters: California, US Founded: 2010 Workforce: ~50-200 Company Working: Neofect develops innovative smart rehabilitation solutions to help patients with neurological and musculoskeletal injuries. Neofect utilizes portable, lightweight, and affordable equipment to perform training exercises. Its smart rehabilitation solutions are designed to allow therapy training through games. The company offers clinically proven rehab programs customized to each patient for a faster recovery. Neofect smart rehabilitation solutions are developed by utilizing clinical evidence, which provides optimal therapies for each patient on the basis of proprietary algorithms and clinical data. It also reflects the patient’s personal motivation to maximize their rehabilitation training. Neofect was awarded the VirtualTech award and MedTech Breakthrough award for its Smart Board for Home NextGen. It is a gamified rehabilitation device for stroke patients to be used at home.
XRHealth
Company Headquarters: Boston, US Founded: 2016 Workforce: ~11-50 Company Working: XRHealth is the first VR/AR Telehealth platform in the world. XR stands for Extended Reality and includes Virtual Reality (VR), Augmented Reality (AR), and Mixed Reality (MR). The company’s telehealth platform provides innovative, immersive, and therapeutic applications that address a wide variety of neurocognitive, emotional, and physical symptoms. These applications are combined with an advanced data portal that utilizes artificial intelligence (AI) and cloud-computing algorithms to deliver meaningful data analytics for monitoring and managing patients remotely. The platform enables two-way interactions between patients and healthcare providers. The VR/AR telehealth platform of XRHealth is ISO certified, FDA certified, and HIPAA compliant.
MindMaze
Company Headquarters: Lausanne, Switzerland Founded: 2012 Workforce: ~200 Company Working: MindMaze is a global leader in digital neuro-therapeutics (DTx) solutions dedicated to accelerating the brain's ability to recover, learn, and adapt. It is a medical device company that specializes in neurorehabilitation, virtual reality, brain imaging, neurotechnology, 3D technology, neural prediction, brain computer interface, and engineering. It works at the intersection of neuroscience, bio-sensing, engineering, mixed reality, and artificial intelligence. Its healthcare division is addressing some of neurology's most difficult problems, such as stroke, Alzheimer's disease, and Parkinson's disease, by developing a universal platform for brain health and recovery and novel digital therapeutic interventions. MindMaze's ground-breaking FDA-cleared and CE-marked neuro-digital therapeutics help patients recover from a wide range of critical neurological conditions. It is Switzerland's first unicorn, with offices in Lausanne, Baltimore, London, Paris, and Mumbai.
Jintronix
Company Headquarters: Montreal, Canada Founded: 2010 Workforce: 11-50 Company Working: Jintronix was founded in 2010 to leverage motion capture technology and transform physical rehabilitation. The company offers an innovative solution in the area of physical therapy. Jintronix is developing a cost-effective physical rehabilitation software for hospitals, clinics, and home use. It works to assist with the delivery of physical therapy by leveraging Kinect technology and brings together themes that are resonating with therapists, physicians, and patients around the world. The company’s unique telemedicine service allows patients to practice clinically designed rehabilitation exercises from anywhere. In the case of long-distance patients, this telemedicine platform allows therapists to assign exercises and monitor patient's progress in mobility. It received 510(k) clearance from the US Food and Drug Administration (FDA) for the Jintronix rehabilitation system. Currently, the Jintronix program is available in 10 different countries.
Novavax, Inc.
Company Headquarters: Maryland, US Founded: 1987 Workforce: ~2,500 Company Working: Novavax, Inc. is a biotechnology company that commercializes and develops vaccines to prevent a wide range of infectious diseases. It designs recombinant nanoparticle vaccine technology that produces a strong immune response against a variety of pathogens. It is partnered with leading biopharma organizations, government agencies, research institutions, and foundations, namely the Coalition for Epidemic Preparedness Innovations (US), the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (US), the Serum Institute of India Pvt. Ltd. (India), SK Bioscience (South Korea), CPL Biological (India), and Takeda Pharmaceuticals (US). It has seven research and manufacturing facilities. It has presence in regions namely North America, Europe, and the Middle East and Africa
Ology Bioservices, Inc
Company Headquarters: Florida, US Founded: 1999 Workforce: ~800 Company Working: Ology Bioservices, Inc. is an integrated biopharmaceutical company that develops and manufactures biopharmaceuticals and medical devices. It specializes in cell therapy, gene therapy, viral vectors, antibodies, oncolytic viruses, biopharmaceutical manufacturing, and vaccines. It has collaboration and partnerships with recognized government agencies, namely the Department of Defense and Medical Countermeasures Advanced Development and Manufacturing, which support it in developing biodefense products. Moreover, it has decades of experience in developing, licensing, and manufacturing proteins, therapeutics, and vaccines. It develops products to offer both commercial customers and US governments. Furthermore, it is a wholly owned company of National Resilience, Inc. (US), and assisting Resilience through its services includes regulatory support from preclinical through licensure and cGMP manufacturing up to biosafety level 3 (BSL3).
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Neurorehabilitation Gaming Systems Market